References

1 UNAIDS, “global HIV statistics fact sheet 2021,” https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf, Accessed 26 Nov 2021.
2 Barik SK, Bansal AK, Mohanty PS, Tripathy SP, Hanna LE, Karunaianantham R et.al. Detection of Drug Resistance Mutations in the Reverse Transcriptase Gene of HIV-1-Infected North Indian Population Failing First-Line Antiretroviral Therapy ”A Follow-Up Cohort Study”. AIDS Res Hum Retroviruses. 2021;37(10):796-805.
3 Alene M, Awoke T, Yenit MK, Tsegaye AT, Yismaw L, Yeshambel R. Second-line antiretroviral therapy regimen change among adults living with HIV in Amhara region: a multi-centered retrospective follow-up study. BMC Res Notes. 2019; 12(1): 407.
4 Martinez-Vega R, De La Mata NL, Kumarasamy N, et al. Durability of antiretroviral therapy regimens and determinants for change in HIV-1-infected patients in the TREAT Asia HIV Observational Database (TAHOD-LITE). Antivir Ther. 2018; 23(2): 167-78.
5 Ajose O, Mookerjee S, Mills EJ, Boulle A, Ford N. Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis. AIDS. 2012; 26(8): 929-38.
6 Edessa D, Sisay M, Asefa F. Second-line HIV treatment failure in sub-Saharan Africa: A systematic review and meta-analysis. PloS one. 2019; 14(7): e0220159.
7 Zenebe Haftu A, Desta AA, Bezabih NM, et al. Incidence and factors associated with treatment failure among HIV infected adolescent and adult patients on second-line antiretroviral therapy in public hospitals of Northern Ethiopia: Multicenter retrospective study. PloS one. 2020; 15(9): e0239191.
8 World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. World Health Organization. Geneva, Switzerland; 2013.
9 Development of China ”Free ART Manual” http://www.aizhi.org/UploadSoft/2005321103838886.pdf,Accessed Dec. 2021.
10 Zhang M, Shang M, Yang W, Chen J, Wang Z, Shang H. Treatment effect and drug-resistant mutations in Chinese AIDS patients switching to second-line antiretroviral therapy. PloS one. 2014; 9(10): e110259.
11 Chen J, Zhang M, Shang M, Yang W, Wang Z, Shang H. Research on the treatment effects and drug resistances of long-term second-line antiretroviral therapy among HIV-infected patients from Henan Province in China. BMC Infect Dis. 2018; 18(1): 571.
12 Dou Z, Chen RY, Wang Z, et al. HIV-infected former plasma donors in rural Central China: from infection to survival outcomes, 1985–2008. PloS one. 2010; 5(10): e13737.
13 Editor Group, Handbook of China’s free ART program. 3rd ed. Beijing: Ren Min Wei Sheng Chu ban She; 2012.
14 Liu ZB, Wang X, Liu HJ, et al. Treatment of acquired immunodeficiency syndrome with Chinese medicine in China: opportunity, advancement and challenges. Chin J Integr Med. 2013; 19(8): 563-7.
15 Jin YT, Guo HJ, Wang X, et al. Traditional Chinese Medicine Could Increase the Survival of People Living with HIV in Rural Central China: A Retrospective Cohort Study, 2004-2012. Am J Chin Med. 2014; 42(6): 1333-44.
16 Jin YT, Liu ZB, Chen XM, et al. Survival of people living with HIV after treatment with traditional Chinese medicine in Henan province of China: a retrospective cohort study. J Tradit Chin Med. 2014; 34(4): 430-6.
17 Zhu JR, Gao RL, Zhao PP, Lu GP, Zhao D, Li JJ. Chinese guidelines for prevention and treatment of dyslipidemia in adults (2016 Revision)[J]. Chinese Journal of Circulation,2016,31(10):937-953.
18 Sulkowski MS, Thomas DL, Chaisson RE, Moore RD. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA. 2000; 283(1): 74-80.
19 Erythrocyte diseases (anemia) Group, Hematology Branch of Chinese Medical Association. Multidisciplinary expert consensus on the diagnosis, treatment and prevention of iron deficiency and iron deficiency anemia (2022 edition) [J]. Chinese medical journal, 2022102 (41): 3246-3256.
20 Cao WJ, Yao YM, Wei W, Lin F, Lu JD, Yuan Z. Survival time and related factors on HIV/AIDS patients in Guizhou province from 1995 to 2018. Zhonghua liu xing bing xue za zhi. 2020; 41(4): 557-61.
21 Liang Y, Yang WJ, Sun DY, Li N, Wang Z. Survival analysis on Former Plasma Donors living with HIV/AIDS after initiation of antiretroviral therapy in Henan province, 2002-2017. Zhonghua liu xing bing xue za zhi. 2019; 40(6): 638-42.
22 Pujades-Rodríguez M, Balkan S, Arnould L, Brinkhof MA, Calmy A. Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries. JAMA. 2010; 304(3): 303-12.
23 Li M, Tang W, Bu K, et al. Mortality among People Living with HIV and AIDS in China: Implications for Enhancing Linkage. Sci Rep. 2016, 6: 28005.
24 Mangal TD, Meireles MV, Pascom ARP, de Almeida Coelho R, Benzaken AS, Hallett TB. Determinants of survival of people living with HIV/AIDS on antiretroviral therapy in Brazil 2006-2015. BMC Infect Dis. 2019; 19(1): 206.
25 Zhu, Keying., Xu, Qianlei., Xu, Qianlei., Ma, Yanmin., Li, Pengyu.. Suboptimal immune recovery and associated factors among people living with HIV/AIDS on second-line antiretroviral therapy in central China: A retrospective cohort study. Journal of medical virology, 2022, .
26 Ahn MY, Jiamsakul A, Khusuwan S, et al. The influence of age-associated comorbidities on responses to combination antiretroviral therapy in older people living with HIV. J Int AIDS Soc. 2019; 22(2): e25228.
27 Ross J, Jiamsakul A, Kumarasamy N, et al. Virological failure and HIV drug resistance among adults living with HIV on second-line antiretroviral therapy in the Asia-Pacific. HIV Med. 2021; 22(3): 201-211.
28 Lundgren JD, Mocroft A. Anemia and survival in human immunodeficiency virus. Clin Infect Dis. 2003; 37 Suppl 4: S297–S303.
29 Santiago-Rodriguez EJ, Mayor AM, Fernandez-Santos DM, Ruiz-Candelaria Y, Hunter-Mellado RF. Anemia in a cohort of HIV-infected Hispanics: prevalence, associated factors and impact on one-year mortality. BMC Res Notes. 2014; 7: 439.
30 Nigussie F, Alamer A, Mengistu Z, Tachbele E. Survival and Predictors of Mortality Among Adult HIV/AIDS Patients Initiating Highly Active Antiretroviral Therapy in Debre-Berhan Referral Hospital, Amhara, Ethiopia: A Retrospective Study. HIV/AIDS. 2020; 12: 757-768.
31 Puoti M, Moioli MC, Travi G, Rossotti R. The burden of liver disease in human immunodeficiency virus-infected patients. Semin Liver Dis. 2012; 32(2): 103-113.
32 Taborelli M, Suligoi B, Toffolutti F, Frova L, Grande E, Grippo F, et al. Excess liver‐related mortality among people with AIDS compared to the general population: an Italian nationwide cohort study using multiple causes of death. HIV Med. 2020, 21(10): 642-9.
33 Jin YT, Wang X, Li ZB, et al. Survival of AIDS Patients Treated with Traditional Chinese Medicine in Rural Central China: A Retrospective Cohort Study, 2004–2012. Evid Based Complement Alternat Med. 2015, 2015: 282819.
34 Wang Y, Jin F, Wang Q, Suo Z. Long-Term Survival of AIDS Patients Treated with Only Traditional Chinese Medicine. Altern Complement Ther. 2017; 23(2): 60-2.
35 Li X, Li H, Li C, Xia W, Li A, Li W. Traditional Chinese Medicine Can Improve the Immune Reconstruction of HIV/AIDS Patients. AIDS Res Hum Retroviruses. 2020; 36(4): 258-9.
36 Wang DL, Ma SN, Ma YM, Guo HJ, Li PY, Yang CL et al. Effect of Traditional Chinese Medicine therapy on the trend in CD4+T-cell counts among patients with HIV/AIDS treated with antiretroviral therapy: a retrospective cohort study. Evid Based Complement Alternat Med, 2021, 5576612.